期刊文献+

通络方剂对1型糖尿病大鼠肾脏Ang Ⅱ、VEGF、ERK1/2表达的影响 被引量:4

Effects of Tongluo recipe on renal expression of Ang Ⅱ,VEGF,and ERK1/2 in rat models of type 1 diabetes mellitus
下载PDF
导出
摘要 目的研究通络方剂对链脲佐菌素(STZ)诱导的1型糖尿病大鼠肾脏组织ERK1/2信号转导通路的影响及对肾脏的保护机制。方法健康SD大鼠随机分为正常组(10只)和造模组。造模组给予单次腹腔注射STZ 60mg/kg,造模成功后按体质量随机分为5组:糖尿病非治疗组,通络方剂低剂量组[0.5g/(kg.d)]、中剂量组[1.0g/(kg.d)]、高剂量组[2.0g/(kg.d)]和氯沙坦组[30mg/(kg.d)],每组10只。适应性饲养1周后,按分组分别给予不同处理,持续给药12周后处死,称体质量,取血检测血糖、血脂、血肌酐、尿素氮,留24h尿检测尿肌酐、尿蛋白、尿微量白蛋白,ELISA法检测血清及肾脏组织中血管紧张素Ⅱ(AngⅡ)的含量,取左肾称质量,H-E、PAS染色观察肾脏病理改变,免疫组织化学法检测p-ERK1/2蛋白的表达,蛋白质印迹法检测VEGF蛋白的表达。结果与糖尿病非治疗组比较,糖尿病大鼠系膜细胞增殖受到抑制,蛋白尿明显降低,体质量增加,肾肥大指数降低,肌酐清除率、血尿素氮降低,肾功能改善,血清及肾组织AngⅡ含量降低,VEGF及p-ERK1/2蛋白的表达降低(P<0.05)。中剂量通络方剂与氯沙坦在改善糖尿病大鼠肾功能及抑制AngⅡ、VEGF、p-ERK1/2表达方面差异无统计学意义。结论通络方剂对糖尿病大鼠肾脏的保护作用可能与抑制AngⅡ、VEGF表达,阻断ERK1/2信号转导通路有关。 Objective To observe the effects of Tongluo recipe on extracellular signal-regulated protein kinase(ERK1/2) pathway in the kidneys of streptozotocin-induced rat models of type 1 diabetes mellitus,and to explore the renoprotective mechanism of Tongluo recipe.Methods Adult male Sprague-Dawley rats were randomly divided into 2 groups: control group(A,n=10) and experimental group.Rats in the experimental group were induced by intraperitoneal injection of streptozotocin(60 mg/kg body mass),and were randomly subdivided into group B(diabetic control,n=10),group C(diabetic rats treated with low dose of Tongluo recipe,0.5 g/[kg·d],n=10),group D(diabetic rats treated with medium dose of Tongluo recipe,1.0 g/[kg·d],n=10),group E(diabetic rats treated with high dose of Tongluo recipe,2.0 g/[kg·d],n=10) and group F(diabetic rats treated with losartan,30 mg/[kg·d],n=10).At the end of the 12th week rats were sacrificed,and the serum glucose,triacylglycerol(TG),total cholesterol(Chol),serum creatinine(Scr),urea nitrogen(BUN) in blood,24-hour urine protein(Upro24),microalbuminuria(MAU),and creatinine in urine(UCR) were examined.The kidney mass/body mass(KM/BM) and creatinine clearance rate(Ccr) were calculated.The left kidneys were collected,weighed and subjected to H-E staining and PAS staining to observe the pathological changes;serum and renal tissue angiotensin Ⅱ(Ang Ⅱ) levels were determined by ELISA;the expression of phosphorylated ERK1/2(p-ERK1/2) was detected by immunohistochemical staining and vascular endothelial growth factor(VEGF) protein expression was determined by Western blotting analysis.Results Compared with group B,group D had a slighter mesangial proliferation under light microscope.Besides,rats in group D had significantly decreased Ccr,BUN,MAU,and Upro24 in the serum,and decreased Ang Ⅱ in the serum and renal tissue,and decreased KM/BM,VEGF and p-ERK1/2 levels in renal tissue compared with rats in group B(P0.05).The medium dose of Tongluo recipe and losartan showed similar effects in improving the renal function and inhibiting Ang Ⅱ,VEGF,and p-ERK1/2 expression of diabetic rats.Conclusion The renoprotective effect of Tongluo recipe may be related to inhibition of ERK1/2 cascade pathway by decreasing the expression of Ang Ⅱ and VEGF.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2011年第9期949-954,共6页 Academic Journal of Second Military Medical University
基金 国家重点基础研究发展计划("973"计划 2005CB523304)~~
关键词 糖尿病肾病 通络方剂 细胞外信号调节蛋白激酶 血管紧张素Ⅱ 血管内皮生长因子 diabetic nephropathies Tongluo recipe extracellular signal-regulated protein kinase angiotensin Ⅱ vascular endothelial growth factor
  • 相关文献

参考文献14

  • 1Fujita H,Omori S,Ishikura K,Hida M,Awazu M. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells[J]. Am J Physiol Renal Physiol, 2004,286:F120- F126.
  • 2de Vriese A S, Tilton R G, Elger M, Stephan C C, Kriz W, Lameire N H. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes [J]. J Am Soc Nephrol,2001,12:993-1000.
  • 3孙亮亮,邹俊杰,石勇铨,刘岩,李文桐,刘明,曲卫,张德刚,刘志民.通络方剂对1型糖尿病大鼠模型肾脏保护作用的形态学研究[J].现代中西医结合杂志,2008,17(22):3419-3420. 被引量:3
  • 4刘岩,邹俊杰,李文桐,李翔,刘志民.通络方药对糖尿病大鼠肾脏的保护作用[J].中国临床康复,2006,10(19):83-85. 被引量:4
  • 5Perlman A, Lawsin L M, Kolachana P, Saji M, Moore J Jr, Ringel M D. Angiotensin Ⅱ regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase[J]. Ann Clin Lab Sci,2004,34:277-286.
  • 6Singh R,Singh A IK, Leehey D J. A novel mechanism for anglo tensin Ⅱ formation in streptozotoein-diabetie rat glomeruli[J]. Am J Physiol Renal Physiol, 2005,288 : F1183-F1190.
  • 7Inoki K, Haneda M, Ishida T, Mori H, Maeda S, Koya D, et al. Role of mitogen activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells[J]. Kidney Int Suppl, 2000,77 : S76-S80.
  • 8de Borst M H,Navis G,de Boer R A,Huitema S,Vis L M,van Gilst W H,et al. Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats[J]. Lab Invest,2003,83 : 1761-1770.
  • 9Senthil D,Choudhury G G,McLaurin C,Kasinath B S. Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic nephropathy[J].Kidney Int, 2003,64 : 468-479.
  • 10Amemiya T, Sasamura H, Mifune M, Kitamura Y, Hirahashi J, Hayashi M, et al. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells[J]. Kidney Int,1999,56:2055 2063.

二级参考文献24

共引文献13

同被引文献109

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部